systems throughout the nation to join them in an effort to maximize patient outcomes. This Pledge is similar to other volume-based policies, such as Medicare's selective reimbursement for solid organ transplant performed by high-volume facilities 6 and lower co-pays for some insurance plans for consumers receiving services at high-volume centers. 7 Proponents argue that the community finally is moving forward with an actionable concept to improve patient outcomes that was first described 36 years ago. 1 This policy, however, also could decrease access to appropriate operative treatment. [8] [9] [10] There are 2 major categories of barriers to access: spatial and nonspatial barriers. 11 Spatial barriers include a physical/geographic distance between patients and providers. Nonspatial barriers emphasize socioeconomic and cultural barriers, such as age, race, education, and social class as well as availability of and options within insurance. 11 Although nonspatial barriers to access have been studied extensively, little is known regarding spatial barriers. Recently, investigators have identified the concept of a spatial barrier as contributing factor to unequal delivery of operative care. 12 Hence, our study focused on the spatial aspect of barriers to access. By limiting complex operations to highvolume centers, the travel burden of patients will increase due to the scarcity of high-volume centers (Fig 1) . National data already have demonstrated an underutilization of pancreatectomy for potentially resectable pancreatic cancer. [13] [14] [15] Such underutilization could be further exacerbated with the increased travel burden associated with such volume-based regionalization. Therefore, this study aimed to identify patients undergoing pancreatectomy whose access to operation may be affected disproportionately by a volume mandate. We attempted to identify vulnerable cohorts by examining the travel patterns of different subpopulations. We hypothesized that racial/ ethnic minorities, self-pay, and Medicaid patients travel less and would be affected disproportionately by a low-volume threshold.
METHODS
We identified all patients who underwent a pancreatectomy in California from 2005 to 2014 from the database of the California Office of Statewide Health Planning and Development, which maintains this database for all Californialicensed facilities. Patients undergoing pancreatectomy were identified by International Classification of Diseases, Ninth Revision (ICD-9) procedure codes of 52.51, 52.52, 52.53, 52.59, 52.6, and 52.7 as a primary or secondary procedure in the inpatient database. Patients were included irrespective of age and indication for operation.
In order to obtain distances from patients' residence to hospitals in California, hospital street addresses and patients' residential ZIP codes were first converted to geographic coordinates (geocoded) using previously described geocoding methodologies. 16 Distance from each patient's residential ZIP code to any possible hospital then was determined via a straight-line distance calculated in miles between the geographic centers of patients' 5-digit residential ZIP codes and geocoded hospital locations. 17 The primary outcome was to determine sensitivity to an added travel burden. Patients were classified as "bypassers" if they travelled past hospitals closer to their residential ZIP code to undergo pancreatectomy. This is in contrast to patients who received their pancreatectomy at the hospital closest to their residential ZIP code, who will be termed "nonbypassers." In order for a hospital to qualify as an option to be bypassed, the hospital has to have performed at least one pancreatectomy for that specific year to indicate availability of pancreatectomy services. Patient bypass of hospital was used as a travel metric over straight line distance in miles, given that it better accounts for geographic density which may confound the distance required to be travelled by the patient. For example, a patient may travel 80 miles but does not bypass any hospitals, because the patient lives in a rural region with no hospitals in close proximity (underestimates travel burden in rural settings). The number of hospitals bypassed then was used as a metric to quantify the patient's travel to get to their destination hospital, and patients who bypass fewer hospitals were deemed to be more sensitive to an added travel burden. In review of the data, there is considerable overlap of distance travelled amongst bypassers and nonbypassers (Fig 2) , suggesting that it is a more accurate travel metric. Straight-line distance in miles then is used as a sensitivity analysis to account for the possibility that number of hospitals bypassed could underestimate travel burden in patients in less dense settings, and the concordance/ discordance between the metrics then is assessed.
All models controlled for patient demographics and comorbidities including age, sex, race/ ethnicity, primary payer, and Charlson comorbidity index. 18 Malignant indication for pancreatectomy was defined as ICD-9 diagnoses code of 152.0, 152. 8 Hospital pancreatectomy volume was recalculated for each year individually, accounting for the possibility that volume at a given hospital could change over time.
Maps were created using ArcMap and ArcGIS software (Esri, Redlands, CA). Statistical analyses were performed using Intercooled Stata software, version 12.0 (StataCorp, College Station, TX). Categorical variables and continuous variables were analyzed using Pearson v 2 tests and Wilcoxon rank-sum tests, respectively. Certain continuous variables, such as age and Charlson comorbidity index scores, were stratified into categories and analyzed as ordinal variables to avoid assumption of linearity. The multivariable analysis was performed via a linear regression model.
RESULTS
Patient demographics. We identified 13,374 patients who underwent a pancreatectomy in the state of California throughout the study period, with 11,006 (82.3%) patients bypassing the hospital closest to their ZIP centroid to receive pancreatectomy (Table I) . Bypassers circumvented a median of 7 hospitals (interquartile range [IQR] 3-20), and travelled a median of 15.9 miles (IQR 7.5-36.7 miles), vs 3.2 miles (IQR 1.8-5.9 miles, P < .001) in the nonbypasser group. Figure 2 depicts the distribution of distance travelled by bypassers and nonbypassers.
Our travel metrics, the number of hospitals bypassed, were then analyzed based on patient characteristics. There were no differences in the number of hospitals bypassed between patients of different sex and Charlson comorbidity index scores. In contrast, patients >80 year old travelled less than their younger counterparts, bypassing a mean of 10.9 ± 9.5 hospitals compared to 14.2 ± 21.3 and 14.3 ± 21.3 hospitals bypassed by the 35 to 49 years and <20 year old age groups respectively (P < .001). Hispanics (8.9 ± 13.5 hospitals bypassed) and African Americans (11.7 ± 19.4 hospitals bypassed) also travelled less when compared with non-Hispanic Whites (13.3 ± 20.4 hospitals bypassed, P < .001). Patients identifying their payer status as self-pay (8.9 ± 15.6 hospitals bypassed) and Medicaid (10.1 ± 17.2 hospitals bypassed) also travelled less when compared with patients with private insurance (13.8 ± 20.4 hospitals bypassed, P < .001).
Independent predictors of travel effort. In an attempt to determine independent patient subgroups who would be more sensitive to an increased travel burden, number of hospitals bypassed was used as an end point in a linear regression model. Advanced age was independently associated with less travel, with patients age 65 to 79 years old (5.32 fewer hospitals bypassed, P = .001) and $80 years old (6.83 fewer hospitals bypassed, P < .001) associated with the least travel when compared with younger patients. These 2 age categories comprised 47% of the study population. African American, Hispanic, and Asian/Pacific islander race/ethnicity also were associated with less travel, travelling by 4.20 (P < .001), 1.44 (P = .002), and 1.69 (P = .002) fewer hospitals respectively, compared with non-Hispanic White patients. These racial minority groups comprised 38% of the study population. Patients who identified their payer status as self-pay (4.64 fewer hospitals bypassed, P < .001) and Medicaid (3.38 fewer hospitals bypassed, P < .001) were associated with less travel when compared with patients with Health Maintenance Organization private insurances. Self-pay or Medicaid payer status accounted for 13% of the study population. The complete linear regression analysis and corresponding percentage of the study population for each subpopulation is depicted in Fig 3. Sensitivity analysis. Straight-line distance in miles was then used as the outcome in a linear regression similar to the model above, accounting for the possibility that number of hospitals bypassed may conversely minimize travel burden in patients in less dense settings. Similarly, there were no differences in miles travelled between patients of different sex and Charlson comorbidity index scores. Patients >80 years old travelled 15.1 miles (95% confidence interval [CI], À6.6 to À23.5 miles, P < .001) less than their younger counterparts. Hispanics (À17.1 miles, 95% CI, À13.7 to À20.6 miles, P <.001) and African Americans (À5.4 miles, 95% À3.2 to À7.6 miles, P < .001) also travelled miles less when compared with nonHispanic whites. Patients identifying their payer status as self-pay (À6.9 miles, 95% CI, À2.6 to À11.2 miles, P = .002) and Medicaid (À14.2 miles, 95% CI, À11.6 to 16.7 miles, P < .001) also travelled less when compared with patients with private insurance.
Travel patterns. Of the 11,006 patients who travelled beyond the hospital closest to their ZIP centroid, 9.8% bypassed a low-volume hospital (<20 cases/year) to receive their pancreatectomy at a high-volume hospital ($20 cases/year). Conversely, 25.3% of patients bypassed a highvolume hospital to receive their pancreatectomy at a low-volume hospital.
DISCUSSION
The conversation surrounding volume-based regionalization was revisited once again when The Volume Pledge was put forth by 3 major health systems. 5 The Pledge is a campaign that will restrict complex procedures to be performed only by hospitals that meet minimum volume standards. Our study raises important considerations regarding its potential impact on access to certain operative procedures for specific, already vulnerable populations. In this study, we found that of all the patients undergoing a pancreatectomy in California, patients' advanced age, minority race/ ethnicity, and presence of Medicaid or uninsured payer status were associated with less travel and would be more sensitive to an increased travel burden as a result of a low-volume threshold.
Previous studies have demonstrated the potentially detrimental impact of volume-based regionalization on access to certain operative procedures in other disease processes. Livingston et al 19 showed that requirements that bariatric procedures be performed at accredited centers increased the median distance Medicare patients were required to travel from 25 miles to 44 miles. Similarly, Stitzenberg et al 20 demonstrated that regionalization of cancer care increased the median travel distance for pancreatic cancer care by 40% and was as great as 72% for patients with esophageal cancer. While recent studies have cited superior outcomes for patients who travel to high-volume centers for complex cancer care, 21, 22 this approach neglects subpopulations who may not be able to travel for certain operative procedures and exacerbates disparity. In fact, these analyses demonstrated that the similar vulnerable cohorts identified in our study also were associated with a lesser probability of receiving operative intervention for operable cancers. Additionally, the degree of regionalization in bariatric operation and cancer care are different from the proposed minimum volume standards of The Pledge, which has not been described previously. For example, there are 50 Accredited Bariatric Centers in California, but only 21 centers that meet the minimum volume requirement of performing 20 pancreatectomies per year (Fig 1) . The present study goes beyond quantifying travel burden by identifying vulnerable cohorts that historically do not or are not able to travel far for their operation. Furthermore, the study utilizes number of hospitals bypassed as a novel metric of travel, which adjusts for geographic density as a potential confounder of distance travelled (Fig 2) . This latter adjustment may explain the incongruent findings of studies that utilize distance travelled as a metric of travel burden. 19, 23, 24 It should be noted that in our study, sensitivity analysis demonstrates that the subpopulation most likely to be affected by a low-volume threshold were similar, whether number of hospitals bypassed or distance travelled in miles were used as end points.
Disparities in receipt of pancreatectomy also have been well described. Bilimoria et al 13 described an astonishing 38.2% of patients with stage I pancreatic cancer without any identifiable contraindications who were not offered operative intervention. An updated analysis of the National Cancer Database in 2013 shows a similarly high rate of nonoperative treatment of stage I 14 The patient characteristics that were associated with an increased risk of not undergoing operative intervention also were similar to our described population of patients who do not generally travel longer distances for certain operative procedures (Table  II) . In California, Medicaid patients are not allowed to receive care outside their county of residence, which may explain their propensity to travel less. Such external constraint on access will only be exacerbated by a Volume Pledge, given that Medicaid patients will not be able to travel further for care. As such, the Volume Pledge may very well widen the disparity in access to certain operative procedures and compound the underutilization of pancreatectomy in specific populations.
There are other interesting findings noted in this study. We found that 25.3% of bypassers (20.8% of entire study population) travelled past a high-volume hospital to receive a pancreatectomy at a low-volume hospital. Such travel patterns may be related to limited insurance networks that have contracts with specific hospitals, leading to an unintended and nonbeneficial consequence. Under a low-volume policy mandate, these patients would be redirected to high-volume hospitals, which for them actually decrease travel. While this effect may be true for some patients, the overall impact for the entire population is unclear. Considering the scarcity of high-volume centers (Fig 1) , however, it is likely that the net impact on travel burden of the population will be negative. While important for future research, exploring the impact of limited access within the insurance network is beyond the scope of this article.
This study should be interpreted in the context of the study design. The analysis only includes patients receiving pancreatectomy in the state of California, thus the generalizability of our findings at the national level is unknown. Geographically, access to certain operative procedures is dictated by the proportion of patients within proximity of a service-providing hospital which differs in every state. 25 California, however, represents the nation's most racially/ethnically diverse state, providing us with sufficient patients in racial/ethnic and payers subgroups for analysis. This 100% capture by the state database allows for complete evaluation of travel effort in all patients receiving operations at California-licensed facilities. In contrast, use of the Medicare database would limit analysis to patients >65 years old. Unfortunately, we do not know why certain patients travelled less for their pancreatectomy. Possible reasons for travelling less could include personal preferences, level of education, financial constraints for both medical and nonmedical expenses, or referral practices of diagnosing providers. Nevertheless, studies have demonstrated that patients who live in rural regions and travel less will often end up in lowvolume hospitals. 26, 27 It is more likely that this finding can be explained by inequality with respect to hospital choice rather than personal preferences or referral practices. Finally, this analysis only identifies patients who underwent pancreatic resection, because the California state database lacks cancer-staging information to appropriately delineate patients with resectable disease who did not undergo resection, and their proximity to high-volume centers.
This study has many important implications. The subpopulations that are associated with less travel effort represent the same subpopulation affected by ongoing policy discussions surrounding the nonemergency medical transportation (NEMT) coverage by Medicaid. Indeed, Medicaid provides NEMT services in the form of programs of direct delivery or public transit voucher to facilitate access to care for low-income beneficiaries who otherwise may not have a reliable and affordable means of getting to health care appointments, including patients with both Medicare and Medicaid coverage. 28, 29 A review of computerized records from a large NEMT broker covering 40 states demonstrated that the majority of NEMT users were elderly patients residing in ZIP codes either predominantly populated by African Americans or from rural regions plagued by poverty. 30 These populations are very similar to the ones demonstrated to be associated with less travel effort in our study and may explain the disparities in the utilization of high-volume hospitals for complex operation. 27, 31 As states adapt to increasing Medicaid enrollment, multiple states, including Iowa and Indiana, have received waivers from Medicaid to restrict coverage of NEMT for beneficiaries. Given the overlap between the vulnerable cohort in our study and those who traditionally utilize NEMT, ongoing evaluation of converging policies is essential as to not exacerbate disparities in access to operation.
The potential pitfalls of a low-volume mandate identified by the present study also should provide impetus to develop alternative solutions, such as improving quality of operative care provided by low-volume hospitals. Quality improvement initiatives identify variations in patient outcomes and aim to close the gap between high-and lowperforming hospitals. Redirecting patients from low-volume hospitals to high-volume hospitals exploits this variation and may further widen this gap in quality. Such redirection should be expected to do little to improve processes of care in low-volume hospitals. Instead, participation of lowvolume centers in Statewide or Regional Quality Collaboratives can help drive improvements through sharing expertise and conducting joint multidisciplinary evaluation of patients. 32, 33 Additionally, identifying care processes beyond volume may help inform and focus quality improvement initiatives at hospitals of any volume. 34, 35 In California, the patients undergoing pancreatectomy who were associated with less travel effort included the elderly, racial minorities, and patients identifying their payer status as self-pay or Medicaid. This vulnerable population may be affected disproportionately by the increased travel burden as a result of minimum volume standards. Expansion of the Volume Pledge should consider strongly the vulnerable populations impacted most by increased travel requirements as well as the broader policy context currently affecting patient access to specific types of complex operations.
